Orbia Advance Co., S.A.B. de C.V. (OTCMKTS:MXCHY - Get Free Report) was the target of a significant decrease in short interest in March. As of March 31st, there was short interest totalling 11,300 shares, a decrease of 24.7% from the March 15th total of 15,000 shares. Based on an average daily volume of 3,300 shares, the days-to-cover ratio is currently 3.4 days. Approximately 0.0% of the shares of the company are short sold.
Orbia Advance Price Performance
MXCHY remained flat at $1.47 during trading on Thursday. Orbia Advance has a twelve month low of $1.18 and a twelve month high of $4.10. The company has a debt-to-equity ratio of 1.47, a quick ratio of 1.04 and a current ratio of 1.52. The firm's fifty day simple moving average is $1.46 and its two-hundred day simple moving average is $1.59.
About Orbia Advance
(
Get Free Report)
Orbia Advance Corporation, SAB. de C.V. provides products and solutions for precision agriculture, building and infrastructure, fluorinated, polymer, and connectivity sectors worldwide. The company offers irrigation systems, agricultural and greenhouse projects, digital farming technologies, and related services; and connectivity solutions, including conduits, cable-in conduit, and other HDPE products and solutions.
Further Reading
Before you consider Orbia Advance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Orbia Advance wasn't on the list.
While Orbia Advance currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.